Optimisons la radioprotection du personnel lors de la radio-immunothérapie des lymphomes par 90Y-Ibritumomab-Tiuxetan

Equivalent doses to the extremities estimated in this study with the protocol “standard” are coherent with the data of the literature. The optimization of the radioprotection of the staff turns out indispensable towards the reproduction of the applications of RIT and at the increase of the frequency of manipulation of this kind of radiopharmaceutical in the future.